We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Health Catalyst Inc (HCAT) USD0.001

Sell:$5.60 Buy:$5.61 Change: $0.44 (7.30%)
NASDAQ:0.64%
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:$5.60
Buy:$5.61
Change: $0.44 (7.30%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:$5.60
Buy:$5.61
Change: $0.44 (7.30%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company’s solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.

Contact details

Address:
10897 SOUTH RIVER FRONT PARKWAY, #300
SOUTH JORDAN
84095
United States
Telephone:
+1 (801) 7086800
Website:
https://www.healthcatalyst.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HCAT
ISIN:
US42225T1079
Market cap:
$353.13 million
Shares in issue:
58.56 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Daniel Burton
    Chief Executive Officer, Director
  • Jason Alger
    Chief Financial Officer, Chief Accounting Officer
  • Daniel Lesueur
    Chief Operating Officer
  • Linda Llewelyn
    Chief People Officer
  • Benjamin Landry
    General Counsel, Corporate Secretary
  • Anne Bickmore
    Chief Product Officer
  • Kevin Freeman
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.